Nick Devoogdt - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Nick Devoogdt

Showing results (151-160 of 153) with videos related to

Pageof 16

Sort By:

You have reached the last page of results.This site can display upto 153 results.

Cancer Research|September 17, 2025

Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 ImmunotherapySana M Arnouk, Daliya Kancheva, Helena Van Damme, et al.

JACC. Cardiovascular Imaging|October 22, 2018

Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of AtherosclerosisMax L Senders, Sophie Hernot, Giuseppe Carlucci, et al.

Science Translational Medicine|October 5, 2021

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal modelsBert Schepens, Loes van Schie, Wim Nerinckx, et al.

Pageof 16

Search research articles

Showing results (151-160 of 153) with videos related to

Sort By:

Pageof 16

You have reached the last page of results.This site can display upto 153 results.

Cancer Research|September 17, 2025

Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 ImmunotherapySana M Arnouk, Daliya Kancheva, Helena Van Damme, et al.

JACC. Cardiovascular Imaging|October 22, 2018

Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of AtherosclerosisMax L Senders, Sophie Hernot, Giuseppe Carlucci, et al.

Science Translational Medicine|October 5, 2021

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal modelsBert Schepens, Loes van Schie, Wim Nerinckx, et al.

Pageof 16